benevolent.ai

What it does

BenevolentAI (Euronext Amsterdam: BAI) is a company that applies advanced AI to accelerate biopharma drug discovery. Their next-generation platform targets the complex decisions that drive R&D, providing life science intelligence. They build technology in the service of science, bringing together science and technology teams to push AI and machine learning to new limits. They leverage their knowledge graph and proprietary ontologies to support scientists and executives in leveraging cutting-edge AI with confidence and precision.

Core features

• ✦AI-driven drug discovery platform
• ✦Knowledge graph and proprietary ontologies
• ✦Life science intelligence

Use cases

• →Accelerating the identification of potential drug candidates
• →Improving the efficiency of drug development processes
• →Providing insights into complex biological systems